This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
(2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurology, 10, 819–828. doi: 10.1016/S1474-4422(11)70145-4.
et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer's disease. New England Journal of Medicine, 367, 795–804.
, V. F.Reyna
, R. C.Petersen
, G. E.Smith
and E. S.Taub
(2011). Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study. Neuropsychology, 25, 679–689. doi: 10.1037/a0024483.
(1984). Additive and multiplicative models for relative survival rates. Biometrics, 40, 51–62.
et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7, 181–184.
F. F.de Oliveira
, P. H.Ferreira Bertolucci
, E. S.Chen
and M. C.Smith
(2014). Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia. Neurology India, 62, 625–630. doi:10.4103/0028-3886.149384.
, G. W.Small
and S. Y.Bookheimer
(2012). Family history and APOE-4 genetic risk in Alzheimer's disease. Neuropsychological Review, 22, 298–309. doi: 10.1007/s11065-012-9193-2.
(1977). The efficiency of Cox's likelihood function for censored data. Journal of the American Statistical Association, 72, 557–565.
et al. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA, 278, 1349–1356.
et al. (2011). A pilot study of gene/gene and gene/environment interactions in Alzheimer disease. Clinical Medicine & Research, 9, 17–25. doi: 10.3I2l/cmr.20I0.894.
, W. W.Barker
, R. L.Ownby
(2004). No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly. International Journal of Geriatric Psychiatry, 19, 1131–1139. doi:10.1002/gps.1193.
, M. J.Owen
(2011). Alzheimer's disease genetics: current knowledge and future challenges. International Journal of Geriatric Psychiatry, 26, 793–802. doi: 10.1002/gps.2628.
et al. (2006). Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. Journal of the American Geriatrics Society, 54, 1348–1354.
et al. (2000). Validation of the NPI-Q: a brief clinical form of the neuropsychiatric inventory. The Journal of Neuropsychiatry and Clinical Neurosciences, 12, 233–239.
(2014). Sleep reduction: a link to other neurobiological diseases. Sleep and Biological Rhythms, 12, 150–161. doi:10.1111/sbr.12066.
(2015). How large is the gap between self-report and assessed mental health and does it impact older adult mental health service utilization?. Journal of Gerontological Social Work, 58, 3–19. doi:10.1080/01634372.2014.919978.
(2013). Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurology, 70, 1544–1551. doi:10.1001/jamaneurol.–.4215.
et al. (2015). Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger and older adults. Psychosomatic Medicine, 77, 480–492. doi: 10.1097/PSY.0000000000000190.
(2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243–252.
and E. M.Stadlan
(1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 34, 939–944.
et al. (2006). The uniform data set (UDS): clinical and cognitive variables and descriptive data from Alzheimer's disease centers. Alzheimer Disease and Associated Disorders, 20, 210–216.
, M. C.Mendoza
and H. H.Klünemann
(2014). A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease. Acta Neurologica Belgica, 114, 25–31.
et al. (2014). The interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiology of Aging, 35, 1318–1324. doi:10.1016/j.neurobiolaging.2013.12.030.
et al. (2007). The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biological Psychiatry, 62, 472–478.
and S. Z.Marsala
(2014). Sleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patients. Journal of the Neurological Sciences. doi: 10.1007/s10072-014-1870-x.
et al. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology, 43, 1467–1472.
(2011). Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment. Neurobiology of Aging, 32, 778–790. doi:10.1016/j.neurobiolaging.2009.04.021.
et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 280–292. doi:10.1016/j.jalz.2011.03.003.
et al. (2009). The Alzheimer's disease centers’ uniform data set (UDS): the neuropsychological test battery. Alzheimer Disease and Associated Disorders, 23, 91. doi: 10.1097/WAD.0b013e31819c7dd.
and G. T.Grossberg
(2010). Circadian rhythm disturbances in patients with Alzheimer's disease: a review. International Journal of Alzheimer's Disease, 2010, 1–9. doi:10.4061/2010/716453.
et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342, 373–377. doi:10.1126/science.1241224.
et al. (2004). Sleep/Wake disruption in Alzheimer's disease: APOE status and longitudinal course. Journal of Geriatric Psychiatry & Neurology, 17, 20–24. doi:10.1177/0891988703261994.